Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1 (Q35832326)

From Wikidata

Jump to navigation Jump to search

scientific article published in February 1993

Language	Label	Description	Also known as
English	Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1	scientific article published in February 1993

Statements

scholarly article

1 reference

Europe PubMed Central

10 August 2017

Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1 (English)

1 reference

Europe PubMed Central

10 August 2017

monoclonal antibody

1 reference

based on heuristic

inferred from title

3

object named as

Olsson H

1 reference

Europe PubMed Central

10 August 2017

author name string

Kreipe H

1

1 reference

Europe PubMed Central

10 August 2017

Alm P

2

1 reference

Europe PubMed Central

10 August 2017

Hauberg M

4

1 reference

Europe PubMed Central

10 August 2017

Fischer L

5

1 reference

Europe PubMed Central

10 August 2017

Parwaresch R

6

1 reference

Europe PubMed Central

10 August 2017

language of work or name

0 references

publication date

1 February 1993

1 reference

Europe PubMed Central

10 August 2017

The American Journal of Pathology

1 reference

Europe PubMed Central

10 August 2017

142

1 reference

Europe PubMed Central

10 August 2017

2

1 reference

Europe PubMed Central

10 August 2017

651-657

1 reference

Europe PubMed Central

10 August 2017

Cell kinetics as a prognostic marker in node-negative breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Interobserver reproducibility of histopathological features in stage II breast cancer. An ECOG study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Growth fractions and estrogen receptors in human breast cancers as determined in situ with monoclonal antibodies.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

New approach to assessing lung tumours in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Biological grading of breast cancer using antibodies to proliferating cells and other markers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

A randomized clinical trial evaluating sequential methotrexate and fluorouracil in the treatment of patients with node-negative breast cancer who have estrogen-receptor-negative tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Cytophotometric estimation of cell proliferation in breast cancer. Correlation to the clinical course during long-term follow-up.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Flow cytometry in primary breast cancer: improving the prognostic value of the fraction of cells in the S-phase by optimal categorisation of cut-off levels

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Ploidy analysis and S-phase fraction determination by flow cytometry of invasive adenocarcinomas of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Prognosis and breast cancer. Recognition of lethal and favorable prognostic types

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Proliferating cell nuclear antigen (PCNA) immunolocalization in paraffin sections: an index of cell proliferation with evidence of deregulated expression in some neoplasms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Comparative assessment of proliferation and DNA content in breast carcinoma by image analysis and flow cytometry.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA). Structural conservation and the detection of a nucleolar form

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1886747

11 July 2018

Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of tumor cell kinetics by immunohistochemistry in carcinoma of breast

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of adjuvant chemotherapy in high-risk node-negative breast cancer. An intergroup study

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant therapy of node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relationship of cytosolic estrogen and progesterone receptor content and the growth fraction in human mammary carcinomas

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of hormone receptors in breast carcinoma by immunocytochemistry and image analysis. II. Estrogen receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Indicators of prognosis in node-negative breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki-67 immunostaining in human breast tumors and its relationship to prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KiS1--a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prediction of early course of breast carcinoma by thymidine labeling

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Proliferation marker Ki-67: correlation with histological diagnosis, neoplasm grading and clinical course]

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitation and estimation of lymphocyte subsets in tissue sections. Comparison with flow cytometry

1 reference

https://pubmed.ncbi.nlm.nih.gov/8094598

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

10 August 2017

1 reference

Europe PubMed Central

10 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35832326&oldid=1647864698"